Ignite Creation Date:
2024-05-06 @ 4:07 PM
Last Modification Date:
2024-10-26 @ 2:04 PM
Study NCT ID:
NCT04888468
Status:
COMPLETED
Last Update Posted:
2022-03-18
First Post:
2021-05-12
Brief Title:
Phase I Study of pCAR-19B in the Treatment of CD19-positive RelapsedRefractory B-ALL in Children and Adolescents
Sponsor:
Chongqing Precision Biotech Co Ltd
Organization:
Chongqing Precision Biotech Co Ltd
Organization Data
Organization:
Chongqing Precision Biotech Co Ltd
Class:
INDUSTRY
Study ID:
PB01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Chongqing Precision Biotech Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None